Literature DB >> 8558722

Urodynamic effects of intravesical oxybutynin chloride in conscious rats.

O Yokoyama1, Y Ishiura, Y Nakamura, M Ohkawa.   

Abstract

PURPOSE: To examine the factors of intravesical oxybutynin influencing the cystometrogram in normal conscious rats at various pH levels and concentrations of oxybutynin.
MATERIALS AND METHODS: A cystostomy catheter was implanted into the bladders of male Sprague-Dawley rats. We compared the urodynamic effects of intravesical oxybutynin dissolved in pH 4.44, 6.44 and 8.44 buffer. Two concentrations of oxybutynin solution were adopted, 0.06 and 0.6 mg./ml., and were dissolved in each pH buffer.
RESULTS: Although a 26% increase in bladder capacity was recognized 1 hour after instillation of pH 8.44, 0.06 mg./ml. oxybutynin, no significant difference was found in comparison with control rats. At the concentration of 0.6 mg./ml., bladder capacity markedly decreased 30 minutes to 1 hour after instillation even at pH 6.44 and 8.44. Significant decreases in detrusor contraction pressure were recognized 30 minutes to 1 hour after instillation. However, there were no significant differences among the 3 pH oxybutynin solutions. Compared with preinstillation values, significant increases in residual urine rates were observed in all pH oxybutynin solutions. Furthermore, the residual urine rate after instillation of pH 8.44 oxybutynin solution differed significantly from that of pH 4.44 oxybutynin.
CONCLUSION: Our results demonstrate that pH and concentration of intravesical oxybutynin solution may play an important role in relaxation of the bladder. A high concentration of oxybutynin is considered irritating to the bladder mucosa.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8558722

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  3 in total

1.  Oxybutynin extended-release: a review of its use in the management of overactive bladder.

Authors:  M Asif A Siddiqui; Caroline M Perry; Lesley J Scott
Journal:  Drugs       Date:  2004       Impact factor: 9.546

2.  Urodynamic effects of oxybutynin and tolterodine in conscious and anesthetized rats under different cystometrographic conditions.

Authors:  Patrizia Angelico; Cristina Velasco; Luciano Guarneri; Giorgio Sironi; Amedeo Leonardi; Rodolfo Testa
Journal:  BMC Pharmacol       Date:  2005-10-11

3.  Characterization of bladder selectivity of antimuscarinic agents on the basis of in vivo drug-receptor binding.

Authors:  Shizuo Yamada; Shiori Kuraoka; Ayaka Osano; Yoshihiko Ito
Journal:  Int Neurourol J       Date:  2012-09-30       Impact factor: 2.835

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.